Fabry

Resarch Center Chiesi Farmaceutici SpA Parma

Marketing

Chiesi survey shows how Fabry drugs are failing patients

The survey found widespread unmet needs among Fabry disease patients taking drugs such as Sanofi’s Fabrazyme.

Nick Paul Taylor Apr 24, 2024 10:25am

fda

Post FDA turnabout, Amicus' Fabry drug Galafold gets green light

Aug 13, 2018 12:25pm